Clinical Trials Logo

Clinical Trial Summary

DCE-MRI were performed in sixty adults (hips and lumbar spine). For each region of interest studied, the investigators determined the morphology of each time-concentration curve (TCC) and calculated semi-quantitative and pharmacokinetic parameters: initial slope (IS), area under the curve (AUC), time to peak (TTP), Ktrans, Kep and Ve. Clinical data were collected anamnestically.


Clinical Trial Description

MRI protocol Patients were examined on a 3T MR scan (Ingenia, Philips Healthcare, The Netherlands). Conventional sequences were acquired depending on the clinical problem. A T1 spin echo sequence imaged the right hip in the coronal plane. A previously described Dynamic 3D T1 Spoiled Gradient Echo covered the right hip (8). Its main features were as follows. 94 axial slices covered a Field of View (FOV) of 228 x 130 x 169 mm. TR, TE, flip angle and bandwidth per pixel were respectively 4.5 and 2.1 ms, 10°, 389 Hz. Acquisition and reconstruction matrix were 64 x 66 and 128 x 128 respectively. Temporal resolution was 13.5 seconds.

Three variable flip angles (VFA) sequences (3°, 10° and 17°) were acquired before injection. Each acquisition lasted 55 seconds. Five baseline scans were acquired. 0.1 mmol/kg of gadoteric acid (DOTAREM, Guerbet, France) were injected at the beginning of the sixth scan at a rate of 2.5ml/sec followed by 20cc of saline flush. Twenty dynamic scans were collected. Total examination time was 9 minutes.

Post-processing The investigators analyzed DCE images with the open-source software Osirix and DCE tool software (http://kyungs.bol.ucla.edu/software/DCE_tool/DCE_tool.html). A ROI was deposed in the common femoral artery to determine Arterial Input Function. T1 map was calculated from VFA acquisitions. The precise r1 relaxivity (3.4) of the contrast agent was introduced. These elements were used to calculate the time / gadolinium concentration curve. Tofts model was used.

The morphology of the curve was assessed visually according to the description made by van Rijswik (10). For each ROI, semi-quantitative and pharmacokinetic parameters were calculated: initial slope (IS), area under the curve (AUC), time to peak (TTP), transfer constant (Ktrans), rate constant (Kep) and extravascular-extracellular space volume (Ve). IS calculation included points 5 to 15. AUC and TTP were calculated from points 5 to 25. Parametric maps were obtained for the illustration of this work, but were not used for the analysis itself in order to avoid bias in the deposition of ROIs. ;


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT02371824
Study type Observational
Source University Hospital, Lille
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date October 2014

See also
  Status Clinical Trial Phase
Recruiting NCT00044122 - Study of Factors Regulating Mast Cell Proliferation
Completed NCT03644420 - Evaluation of Patients With Knee Osteoarthritis Receiving a Prosthesis
Recruiting NCT03792594 - Autologous Bone Marrow Concentration for Rotator Cuff Tear
Recruiting NCT03794622 - Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union
Active, not recruiting NCT02524613 - Prospective Bone Marrow Biopsy Safety and Efficacy Study N/A
Completed NCT00760227 - Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation N/A
Enrolling by invitation NCT04024670 - The Impact of Arts-Based Interventions on Patient Hospital Experience N/A
Recruiting NCT03793530 - Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery N/A
Recruiting NCT03787329 - Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head